Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

Groundbreaking Study Reveals Critical Role of Iron, Paving the Way for New TreatmentsA groundbreaking study led by a global ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Cancer-hunting antibodies coupled with a natural compound found in soil microbes proved a powerful combination against an aggressive type of blood cancer, according to a new study from scientists at ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...